The strongest increase in the FSGS patient screen was found for osteopontin, a secreted glycophosphoprotein that can regulate many signaling processes highly relevant for the immune system and FSGS, including interleukins, NFκB, TGF-β, and CD44 [38]. This evidence concerns the gene NFKB1 and focal segmental glomerulosclerosis.